bpc-157 dosing (Common Protocols), πΉ Oral / Subcutaneous, β’ 500 mcg daily, β’ Duration: 6 weeks, πΉ Intramuscular / Peritendinous, β’ 1 mg daily, β’ Duration: 6 weeks, β οΈ Note:, Not approved by FDA or BPC-157 Dosage Calculator: Units, mL
Description
Increased cellular energy Higher NAD+ levels translate directly to improved cellular energy production
Weeks 7-12: Sustained Response The 7-12 week period represents the timeframe used in the most successful clinical trials
If insomnia persists beyond 3 weeks despite morning timing, consult a physician
What is the difference between a lipotropic injection and a B12 injection
